Disease Markers

Table of Contents: 2002

  • Disease Markers -
  • Special Issue
  • Volume 18
  • - Article ID 496345

Immunohistochemical Expression of Retinoblastoma Gene Product in Normal, Hyperplastic and Malignant Endometrium. Correlation with p53 Protein Expression, c-erbB-2, Hormone Receptors’ Status and Proliferative Activity

E. E. Ioachim | A. C. Goussia | ... | S. Stefanaki
  • Disease Markers -
  • Special Issue
  • Volume 18
  • - Article ID 647961

Evaluation of Nitric Oxide (NO) Levels in Hepatitis C Virus (HCV) Infection: Relationship to Schistosomiasis and Liver Cirrhosis among Egyptian Patients

Mahmoud Ismail Hassan | Samar Kamal Kassim | ... | Ali Khalifa
  • Disease Markers -
  • Special Issue
  • Volume 18
  • - Article ID 194075

Surfactant Protein B Intron 4 Variation in German Patients with COPD and Acute Respiratory Failure

Carola Seifart | Alexandra Plagens | ... | Joanna Floros
  • Disease Markers -
  • Special Issue
  • Volume 18
  • - Article ID 418383

The Stromelysin-1 5A/6A Promoter Polymorphism Is a Disease Marker for the Extent of Coronary Heart Disease

Adelheid Schwarz | Werner Haberbosch | ... | Andreas Gardemann
  • Disease Markers -
  • Special Issue
  • Volume 18
  • - Article ID 843537

Soluble Inter-Cellular Adhesion Molecule-1 in Urban Asian North Indians: Relationships with Anthropometric and Metabolic Covariates

Astha Sethi | Anoop Misra | ... | Naval Kishore Vikram
  • Disease Markers -
  • Special Issue
  • Volume 18
  • - Article ID 156359

Evaluation of Blood Units with Isolated Anti HBC for the Presence of HBV DNA

Abdel-Rahman N. Zekri | Azza A. Awlia | ... | Gamal M. Mabrouk
  • Disease Markers -
  • Special Issue
  • Volume 18
  • - Article ID 505397

Shotgun Proteomics and Biomarker Discovery

W. Hayes McDonald | John R. Yates
  • Disease Markers -
  • Special Issue
  • Volume 18
  • - Article ID 178798

Comprehensive phenotyping and biological marker discovery

Aaron B. Kantor
  • Disease Markers -
  • Special Issue
  • Volume 18
  • - Article ID 438745

Biomarkers and Surrogate Endpoints: How and When might They Impact Drug Development?

Chetan D. Lathia
  • Disease Markers -
  • Special Issue
  • Volume 18
  • - Article ID 589075

Novel Approaches to Identification of Biomarkers for Detection of Early Stage Cancer

Nancy B. Kiviat | Cathy W. Critchlow
  • Disease Markers -
  • Special Issue
  • Volume 18
  • - Article ID 341708

Pharmacogenomic Biomarkers

Sandra C. Kirkwood | Richard D. Hockett
  • Disease Markers -
  • Special Issue
  • Volume 18
  • - Article ID 482953

QT Interval Prolongation as a Biomarker for Torsades de Pointes and Sudden Death in Drug Development

Gregory D. Sides
  • Disease Markers -
  • Special Issue
  • Volume 18
  • - Article ID 212987

Delivery of High-Quality Biomarker Assays

Brian N. Swanson
  • Disease Markers -
  • Special Issue
  • Volume 18
  • - Article ID 929274

Overview of Biomarkers and Surrogate Endpoints in Drug Development

John A. Wagner
  • Disease Markers -
  • Special Issue
  • Volume 18
  • - Article ID 182186
  • - Foreword

Surrogate Endpoints in Medicine

Sudhir Srivastava | John A. Wagner
Disease Markers
 Journal metrics
Acceptance rate34%
Submission to final decision88 days
Acceptance to publication43 days
CiteScore3.500
Impact Factor2.738
 Submit